Chiusura precedente | 3,5450 |
Aperto | 3,5550 |
Denaro | N/D x N/D |
Lettera | N/D x N/D |
Min-Max giorno | 3,5550 - 3,5550 |
Intervallo di 52 settimane | 1,8540 - 3,5550 |
Volume | |
Media Volume | 12.005 |
Capitalizzazione | N/D |
Beta (5 anni mensile) | 0,61 |
Rapporto PE (ttm) | N/D |
EPS (ttm) | N/D |
Prossima data utili | N/D |
Rendimento e dividendo (futuro) | N/D (N/D) |
Data ex dividendo | N/D |
Stima target 1A | N/D |
Publication of a transparency notification – Regulated information(Article 14 of the law of May 2, 2007 on the disclosure of significant shareholdings) Mortsel, Belgium – September 8, 2023 – 7.45 a.m. CET According to Agfa-Gevaert NV’s bylaws, the threshold as from which a shareholding needs to be disclosed, has been set at 3%, 5% and a multiple of 5%. In conformity with the Law of May 2, 2007 regarding the disclosure of significant shareholdings in listed companies, Agfa-Gevaert (Euronext: AGFB
Regulated information – August 23, 2023 - 7:45 a.m. CET The Agfa-Gevaert Group in Q2 2023: continued progress for the growth engines HealthCare IT: Increase in order intake of 11%, revenue increase of 8%Quarter-on-quarter profitability improvement, but service margins under pressure due to cost inflation Digital Print & Chemicals: Good performance of the ZIRFON and Digital Print growth enginesProfitability improvements for ZIRFON and Digital Print offset by: weakness in the electronics industry,
Regulated information – May 9, 2023 - 7:45 a.m. CET The Agfa-Gevaert Group in Q1 2023: HealthCare IT: Increase in order intake of 25%, 4.8% revenue increaseProfitability impacted by cost inflation and unfavorable mix effects Digital Print & Chemicals: Growth driven by Digital Printing and Zirfon membranesSuccessful price increase actions and cost reductions allowed to restore profitability Radiology Solutions: Medical film: volume recovery in China but continuing margin pressure and geopolitical